DOI: 10.55522/jmpas.V11I6.4273

VOLUME 11 - ISSUE 6 NOVEMBER - DECEMBER 2022

Recent advances in lipid based nanovesicles for transdermal drug delivery

Chinthaginjala Haranath, Nara Poojitha, Hindustan Abdul Ahad, Sravani Yarra, Bhargav Eranti

Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapur, Andhra Pradesh, India.

Refer this article

Chinthaginjala Haranath, Nara Poojitha, Hindustan Abdul Ahad, Sravani Yarra, Bhargav Eranti, 2022. Recent advances in lipid based nanovesicles for transdermal drug delivery. Journal of medical pharmaceutical and allied sciences, V 11 - I 6, Pages - 5375 – 5381. Doi: 10.55522/jmpas.V11I6.4273.

ABSTRACT

Lipid-based nanovesicles are the formulations which are used for the delivery of hydrophilic, hydrophobic and amphiphilic drugs or compounds. They are very helpful for the drugs which are hydrophilic and irritant drugs that can be encapsulated and delivered to the target site. They are very advantageous over conventional formulations. Lipid based nanovesicular systems will efficaciously help the drugs addressing the issues of solubility and penetration thereby promotes bioavailability. Now a days lipid based nanovesicles for transdermal delivery of drug has become very useful especially for hydrophilic drugs. The use of the nanovesicles for transdermal drug delivery will overcome the drawbacks associated with the route of drug delivery, such as oral and parenteral. Lipid based nanocarriers includes liposomes, transferosomes, ethosomes, niosomes, ufasomes, spinghosomes, pharmacosomes etc., This review article describes the types, formulation methods, evaluation and the research works done on lipid based nanovesicles for transdermal delivery of the drug.

Keywords:

Lipid based nanovesicles, transdermal, Bioavailability, Absorption, Penetration


Full Text Article